Medicus Pharma Ltd.
MDCX
$1.73
-$0.19-9.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 183.83% | 101.01% | 125.12% | -69.94% | 849.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 187.41% | 69.29% | 200.24% | -34.24% | 929.23% |
| Operating Income | -187.41% | -69.29% | -200.24% | 34.24% | -929.23% |
| Income Before Tax | -818.76% | -70.00% | -198.84% | -65.01% | 23.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -818.76% | -70.00% | -198.84% | -65.01% | 23.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -818.76% | -70.00% | -198.84% | -65.01% | 23.11% |
| EBIT | -187.41% | -69.29% | -200.24% | 34.24% | -929.23% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -369.19% | 2.79% | -97.16% | -17.98% | 83.68% |
| Normalized Basic EPS | -161.12% | 5.94% | -97.20% | -46.83% | 83.68% |
| EPS Diluted | -369.19% | 2.79% | -97.16% | -17.98% | 83.68% |
| Normalized Diluted EPS | -161.12% | 5.94% | -97.20% | -46.83% | 83.68% |
| Average Basic Shares Outstanding | 95.82% | 74.88% | 51.55% | 39.84% | 371.14% |
| Average Diluted Shares Outstanding | 95.82% | 74.88% | 51.55% | 39.84% | 371.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |